Abrams JS - Search Results

1

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

Parkinson DR, Abrams JS, Wiernik PH, Rayner AA, Margolin KA, Van Echo DA, Sznol M, Dutcher JP, Aronson FR, Doroshow JH, et al. Parkinson DR, et al. Among authors: abrams js. J Clin Oncol. 1990 Oct;8(10):1650-6. doi: 10.1200/JCO.1990.8.10.1650. J Clin Oncol. 1990. PMID: 2213101 Clinical Trial.

2

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.

Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M, Paradise C, Kunkel L, Rosenberg SA. Atkins MB, et al. J Clin Oncol. 1999 Jul;17(7):2105-16. doi: 10.1200/JCO.1999.17.7.2105. J Clin Oncol. 1999. PMID: 10561265 Review.

3

High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.

Abrams JS, Rayner AA, Wiernik PH, Parkinson DR, Eisenberger M, Aronson FR, Gucalp R, Atkins MB, Hawkins MJ. Abrams JS, et al. J Natl Cancer Inst. 1990 Jul 18;82(14):1202-6. doi: 10.1093/jnci/82.14.1202. J Natl Cancer Inst. 1990. PMID: 2194036 Clinical Trial.

4

Phase II trial of N-methylformamide in advanced renal cancer.

Abrams JS, Tait N, Silva H, Eisenberger M, Van Echo DA, Olver IN, Aisner J. Abrams JS, et al. Am J Clin Oncol. 1989 Feb;12(1):41-2. doi: 10.1097/00000421-198902000-00009. Am J Clin Oncol. 1989. PMID: 2912020

5

A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.

Eisenberger M, Krasnow S, Ellenberg S, Silva H, Abrams J, Sinibaldi V, Van Echo D, Aisner J. Eisenberger M, et al. J Clin Oncol. 1989 Sep;7(9):1341-5. doi: 10.1200/JCO.1989.7.9.1341. J Clin Oncol. 1989. PMID: 2671289 Clinical Trial.

6

National Cancer Institute-supported clinical trials networks.

Abrams J, Kramer B, Doroshow JH, Varmus H. Abrams J, et al. J Clin Oncol. 2015 Jan 20;33(3):293. doi: 10.1200/JCO.2014.59.5421. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452448 No abstract available.

7

A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.

Belani CP, Egorin MJ, Abrams JS, Hiponia D, Eisenberger M, Aisner J, Van Echo DA. Belani CP, et al. Among authors: abrams js. J Clin Oncol. 1989 Dec;7(12):1896-902. doi: 10.1200/JCO.1989.7.12.1896. J Clin Oncol. 1989. PMID: 2555452

8

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.

Abrams JS, Vena DA, Baltz J, Adams J, Montello M, Christian M, Onetto N, Desmond-Hellmann S, Canetta R, Friedman MA, et al. Abrams JS, et al. J Clin Oncol. 1995 Aug;13(8):2056-65. doi: 10.1200/JCO.1995.13.8.2056. J Clin Oncol. 1995. PMID: 7543562 Clinical Trial.

9

Phase II study of N-methylformamide in patients with advanced colorectal cancer.

Tchekmedyian NS, Kaplan RS, Eisenberger M, Abrams J, Van Echo D. Tchekmedyian NS, et al. Cancer Treat Rep. 1987 May;71(5):541-2. Cancer Treat Rep. 1987. PMID: 3567980 No abstract available.

10

Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.

Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, Panasci L, Muss H, Citron M, Holland J, et al. Aisner J, et al. J Clin Oncol. 1995 Jun;13(6):1443-52. doi: 10.1200/JCO.1995.13.6.1443. J Clin Oncol. 1995. PMID: 7751891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters